Clorazepate Dipotassium Tablet
Product Images NDC 13107-283

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Clorazepate Dipotassium (NDC 13107-283). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurolife Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label.principal Display Panel (3.75 mg 100 Tablets Container Label)

Each tablet contains 3.75 mg of Clorazepate dipotassium. This medication is distributed by Aurobindo Pharma USA, Inc. and is kept in a light-resistant container. The tablets are made in India and should be stored at a temperature of 20° to 25°C (68° to 77°F). It is important to keep the container tightly closed and protect the medication from light and moisture. This medication is only available with a prescription and should be kept out of reach of children. A medication guide is available separately for each patient.*

FDA Label Image

Package Label-principal Display Panel (15 mg (100 Tablets Bottle))

FDA Label Image

Package Label-principal Display Panel (7.5 mg (100 Tablets Bottle))

FDA Label Image

Chemical Structure (Clorazepate Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.